https://www.selleckchem.com/pr....oducts/Staurosporine
The RvD2/LTB ratio at baseline was significantly lower in the poor prognosis group (mRS ≥ 3) than that in the good prognosis group (mRS ≤ 2). Our study indicated that the balance between pro-resolving and proinflammatory mediators was impaired by diabetes in ischemic stroke. The RvD2/LTB ratio may serve as a biomarker of prognosis for ischemic stroke. Our study indicated that the balance between pro-resolving and proinflammatory mediators was impaired by diabetes in ischemic stroke. The RvD2/LTB4 ratio may serve as a biomarker of
Beğen
Yorum Yap
Paylaş
